Aug 16 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. REPORTS SECOND QUARTER 2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* QUALIGEN THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.11
* QUALIGEN THERAPEUTICS INC- QTRLY REVENUES WERE $1.4
MILLION
COMPARED TO ABOUT $1.1 MILLION
* QUALIGEN THERAPEUTICS INC - AS OF JUNE 30, 2022, QUALIGEN
THERAPEUTICS HAD $9.7 MILLION IN CASH
* QUALIGEN THERAPEUTICS INC - BELIEVES ITS CASH IS
SUFFICIENT TO
FUND ITS ANTICIPATED OPERATIONS INTO 2023
Source text for Eikon: [ID: https://bit.ly/3Aqn0AT]
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;;))